182 related articles for article (PubMed ID: 24147158)
1. A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.
Hammam O; Mahmoud O; Zahran M; Sayed A; Salama R; Hosny K; Farghly A
Gastrointest Cancer Res; 2013 Jul; 6(4):107-14. PubMed ID: 24147158
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of TNF a mRNA and VEGF mRNA expression in patients with chronic hepatitis C genotype-4, with and without cirrhosis and hepatocellular carcinoma to predict disease outcome.
Kishta SA; Abd-Alhade AA; Hamam O; Raoof EA; Abeya S
J Egypt Soc Parasitol; 2010 Aug; 40(2):515-30. PubMed ID: 21246958
[TBL] [Abstract][Full Text] [Related]
3. The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma.
Hammam O; Mahmoud O; Zahran M; Aly S; Hosny K; Helmy A; Anas A
Hepat Mon; 2012 Nov; 12(11):e6132. PubMed ID: 23300494
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
5. Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.
El Bassiouny AE; El-Bassiouni NE; Nosseir MM; Zoheiry MM; El-Ahwany EG; Salah F; Omran ZS; Ibrahim RA
Medscape J Med; 2008 Jun; 10(6):130. PubMed ID: 18679533
[TBL] [Abstract][Full Text] [Related]
6. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.
Bassiouny AE; Nosseir MM; Zoheiry MK; Ameen NA; Abdel-Hadi AM; Ibrahim IM; Zada S; El-Deen AH; El-Bassiouni NE
World J Hepatol; 2010 Jan; 2(1):32-41. PubMed ID: 21160954
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
Huang YS; Hwang SJ; Chan CY; Wu JC; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):327-33. PubMed ID: 10389289
[TBL] [Abstract][Full Text] [Related]
9. Significance of pSmad2/3 and Smad4 in hepatitis C virus-related liver fibrosis and hepatocellular carcinoma.
Moussa MM; Helal NS; Youssef MM
APMIS; 2018 Jun; 126(6):477-485. PubMed ID: 29924446
[TBL] [Abstract][Full Text] [Related]
10. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
11. Soluble angiogenesis factors in sera of Egyptian patients with hepatitis C virus infection: correlation with disease severity.
Talaat RM
Viral Immunol; 2010 Apr; 23(2):151-7. PubMed ID: 20373995
[TBL] [Abstract][Full Text] [Related]
12. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
13. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients.
Atta MM; Atta HM; Gad MA; Rashed LA; Said EM; Hassanien Sel-S; Kaseb AO
J Hepatocell Carcinoma; 2016; 3():19-24. PubMed ID: 27574588
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
16. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
17. Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients.
Askoura M; Abbas HA; Al Sadoun H; Abdulaal WH; Abu Lila AS; Almansour K; Alshammari F; Khafagy ES; Ibrahim TS; Hegazy WAH
Pathogens; 2022 Jan; 11(1):. PubMed ID: 35056005
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
19. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Ye G; Qin Y; Lu X; Xu X; Xu S; Wu C; Wang X; Wang S; Pan D
Biochem Biophys Res Commun; 2015 Mar; 459(1):18-23. PubMed ID: 25701390
[TBL] [Abstract][Full Text] [Related]
20. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
